Proper Dietary Management, Follow-up, and Lactase Enzyme Supplementation for Lactose Intolerance
Recruiting now
Conditions studied: Lactose Intolerant, Lactose Malabsorption, Lactose Intolerance
In brief
Lactose intolerance (LI) is considered the clinical syndrome caused by lactose malabsorption (LM). It is possible to identify four causes of lactase deficiency defining four different types of LM: primary (genetic), secondary (acquired), congenital (alactasia), and developmental (in premature infants, so reversible). The aim of this protocol is to investigate through an anonymous online survey the knowledge of the Italian population on clinical, pathophysiological, diagnostic and therapeutic issues of lactose intolerance. Data collected will be divulgated through a publication for both people with IL and nutritionists, enriched with tables and flow charts, to improve the knowledge on lactose intolerance and to support people suffering from this condition. The results of this survey will guide subjects suspected of suffering from lactose intolerance towards a correct diagnosis and a better management.
Key facts
- Study ID
- NCT06773650
- Run by
- European Institute of Oncology
- People needed
- 385
- Starts
- 2025-01-08
- Expected to finish
- 2026-01-01
- Last updated by the study team
- 2025-01-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subjects must be adults (≥18 years of age)
- Willingness to complete the online survey
You may not qualify if…
- Subjects <18 years of age
- Subjects not available to answer the online survey
Where it is running
- European Institute of Oncology — Milan, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.